Antibodies against human CD38
US11230604B2 · kind B2 · utility
0Cited by
9References
119Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 2018 |
| Grant date | Jan 25, 2022 |
| Priority date | — |
| Expiry date | Nov 27, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/91148
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Isolated monoclonal antibodies which bind to human CD38 and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.